Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythropoietic protoporphyria

D J Todd1

  • 1Department of Dermatology, Royal Victoria Hospital, Belfast, Northern Ireland.

The British Journal of Dermatology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Erythropoietic protoporphyria (EPP) is an inherited metabolic disorder causing severe photosensitivity due to ferrochelatase deficiency. Research is clarifying its complex inheritance and exploring gene therapy for future treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous paraneoplastic granulomatous eruptions secondary to metastatic carcinoid tumour.

The British journal of dermatology·2014
Same author

Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: a qualitative study.

Lupus·2012
Same author

Abatacept in the treatment of rheumatoid arthritis.

International journal of clinical practice·2007
Same author

An atypical population of NK cells that spontaneously secrete IFN-gamma and IL-4 is present in the intraepithelial lymphoid compartment of the rat.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Concurrent pilomatrix carcinoma and giant pilomatrixoma.

The Australasian journal of dermatology·2001
Same author

Therapeutic options for erythropoietic protoporphyria.

The British journal of dermatology·2000
Same journal

Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

The British journal of dermatology·2026
Same journal

Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

The British journal of dermatology·2026
Same journal

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
Same journal

Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

The British journal of dermatology·2026
Same journal

Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

The British journal of dermatology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Dermatology

Background:

  • Erythropoietic protoporphyria (EPP) is an inherited disorder of heme biosynthesis.
  • It results from decreased activity of the enzyme ferrochelatase.
  • EPP is characterized by photosensitivity and elevated protoporphyrin levels.

Purpose of the Study:

  • To investigate the complex inheritance patterns of EPP.
  • To review current understanding of EPP's clinical manifestations and complications.
  • To explore potential future therapeutic strategies, including gene therapy.

Main Methods:

  • Analysis of ferrochelatase activity to determine inheritance patterns.
  • Review of clinical and biochemical data in EPP patients.
  • Examination of molecular studies and gene mapping of ferrochelatase.

Related Experiment Videos

Main Results:

  • EPP exhibits complex inheritance, with both autosomal dominant and recessive patterns observed.
  • Photosensitivity causes severe pain upon sun exposure.
  • Acute hepatic failure is a critical complication, often requiring liver transplantation.

Conclusions:

  • Further molecular studies are needed to fully elucidate EPP's inheritance.
  • Current treatments like beta-carotene lack definitive controlled trial evidence.
  • Gene therapy targeting bone marrow stem cells offers future therapeutic hope for EPP.